Inhaled Glucocorticoids for Asthma
- 30 March 1995
- journal article
- review article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 332 (13) , 868-875
- https://doi.org/10.1056/nejm199503303321307
Abstract
Glucocorticoids are the most effective therapy available for patients with asthma. They may be administered either orally or, much more safely, by inhalation. With the recognition that airway inflammation is present even in patients with mild asthma, therapy with inhaled glucocorticoids is now recommended at a much earlier stage.1 However, despite their proved efficacy in the treatment of asthma, enthusiasm for their use has been tempered by concern about systemic side effects. Because of this concern, less effective therapies are often preferred, particularly for children.Mechanism of ActionMolecular MechanismsInhaled glucocorticoids are highly lipophilic. They rapidly enter airway cells, . . .Keywords
This publication has 91 references indexed in Scilit:
- Inhaled Fluticasone PropionateDrugs, 1994
- Absence of posterior subcapsular cataracts in young patients treated with inhaled glucocorticoidsThe Lancet, 1993
- Nedocromil SodiumDrugs, 1993
- The Cost of AsthmaPharmacoEconomics, 1993
- Bone metabolism in children with asthmatreated with inhaled beclomethasone dipropionateThe Journal of Pediatrics, 1993
- BudesonideDrugs, 1992
- A New Approach to the Treatment of AsthmaNew England Journal of Medicine, 1989
- Beclomethasone Dipropionate A Reappraisal of its Pharmacodynamic Properties and Therapeutic Efficacy After a Decade of Use in Asthma and RhinitisDrugs, 1984
- The Value of Maintenance Theophylline in Steroid-Dependent AsthmaNew England Journal of Medicine, 1981
- Treatment of asthma in children with triamcinolone acetonide aerosolJournal of Allergy and Clinical Immunology, 1978